Protective substances against zinc-induced neuronal death after ischemia: Carnosine as a target for drug of vascular type of dementia

Recent Patents on CNS Drug Discovery

Volumn 2, Issue 2, 2007, Pages 145-149

  Kawahara, Masahiro ^a   Konoha, Keiko ^a   Nagata, Tetsuya ^a   Sadakane, Yutaka ^a  

^a KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Calcium homeostasis; Delayed neuronal death; Dementia; Stroke

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALUMINUM; ANSERINE; CALCIUM; CARNOSINE; CHELATING AGENT; CHICKEN BREAST EXTRACT; CLIOQUINOL; EDETATE CALCIUM; GADOLINIUM; GLUTAMIC ACID; GLUTATHIONE; HOMOCARNOSINE; IMIDAZOLE DERIVATIVE; N ACETYLCARNOSINE; NATURAL PRODUCT; NIMODIPINE; OXALOACETATIC ACID; PEPTIDE DERIVATIVE; POLAPREZINC; PYRUVATE SODIUM; PYRUVIC ACID; UNCLASSIFIED DRUG; ZINC;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTHRITIS; ATAXIA; ATHEROSCLEROSIS; AUTISM; BRAIN ISCHEMIA; CATARACT; CELL PROTECTION; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DRUG STRUCTURE; FISH; FRUIT; IN VITRO STUDY; ISCHEMIA; KIDNEY ISCHEMIA; LIVER DISEASE; LUNG INJURY; MULTIINFARCT DEMENTIA; MUSCLE FATIGUE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OSTEOARTHRITIS; PATENT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SEIZURE; STOMATITIS; SYNAPSE; VEGETABLE;

ANIMALS; BRAIN ISCHEMIA; CARNOSINE; CELL DEATH; DEMENTIA, VASCULAR; HUMANS; NEURONS; NEUROPROTECTIVE AGENTS; ZINC;

EID: 34250779929     PISSN: 15748898     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488907780832698     Document Type: Review

References (88)

1. Grossman H, Bergmann C, Parker S. Dementia: a brief review. Mt Sinai J Med 2006; 73:985-92.
2. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 1991; 6:487-98.
3. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297:353-56.
4. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81:741-66.
5. Yokota O, Sasaki K, Fujisawa Y, et al. Frequency of early and late-onset dementias in a Japanese memory disorders clinic. Eur J Neurol 2005; 12: 782-90.
6. de Haan EH, Nys GM, Van Zandvoort MJ. Cognitive function following stroke and vascular cognitive impairment. Curr Opin Neurol 2006; 19:559-64.
7. Tatemichi TK. How acute brain failure becomes chronic: a view of the mechanisms of dementia related to stroke. Neurology 1990; 40:1652-59.
8. Lee JM, Grabb MC, Zipfel GJ, Choi DW. Brain tissue responses to ischemia. J Clin Invest 2000; 106:723-31.
9. 2+ signals and neuronal death in brain ischemia. Stroke 2007; 38: 674-76.
10. Choi DW. Neurodegeneration: cellular defences destroyed. Nature 2005; 433: 696-98.
11. Choi DW. Possible mechanisms limiting N-methyl-D-aspartate receptor overactivation and the therapeutic efficacy of N-methyl-D-aspartate antagonists. Stroke 1990; 21:III20-22.
12. Birkenhager WH, Staessen JA. Progress in cardiovascular diseases: cognitive function in essential hypertension. Prog Cardiovasc Dis 2006; 49:1-10.
13. Chabriat H, Bousser MG. Vascular dementia: potential of antiplatelet agents in prevention. Eur Neurol 2006; 55: 61-69.
14. Demaerschalk BM, Wingerchuk DM. Treatment of vascular dementia and vascular cognitive impairment. Neurologist 2007; 13:37-41.
15. Martinez-Vila E, Murie-Fernandez M, Gallego Perez-Larreya J, Irimia P. Neuroprotection in vascular dementia. Cerebrovasc Dis 2006; 21:106-17.
16. Kawahara M, Kato-Negishi M, and Kuroda Y. Pyruvate blocks zinc-induced neurotoxicity in immortalized hypothalamic neurons. Cellular and Molecular Neurobiology 2002; 22: 87-93.
17. Kawahara M, Kato-Negishi M, Hosoda R, Kuroda Y. Characterization of zinc-induced apoptosis of GT1-7 cells. Biomed Res Trace Elements 2002; 13: 280-281.
18. Konoha K, Sadakane Y., Kawahara M.: Effects of gadolinium and other metal on the neurotoxicity of immortalized hypothalamic neurons induced by zinc. Biomed Res Trace Elements 2004; 15: 275-277.
19. Konoha K and Kawahara M: Zinc-induced apoptotic death of cultured neuronal cells. J KUHW 2004; 5: 247-251.
20. Sadakane Y, Konoha K, Kawahara M. Protective activity of mango ( Mangifera indica L.) fruit against a zinc-induced neuronal cell death is independent of its antioxidant activity. Trace Nutrients Res 2005; 22: 73-79.
21. Konoha K, Sadakane Y, Kawahara M. Zinc neurotoxicity and its role in neurodegenerative diseases. J Health Sci 2006; 52: 1-8.
22. Konoha R, Sadakane Y, Kawahara M. Carnosine protects GT1-7 calls against zinc-induced neurotoxicity: a possible candidate for treatment for vascular type of dementia. Trace Nutrient Res 2006; 23:1-8.
23. Kawahara M, Konoha K, Sadakane Y. Neurotoxicity of zinc: the involvement of calcium homeostasis and carnosine. Biomed Res Trace Elements 2007; 18:26-34.
24. Kawahara M, Konoha K, Sadakane Y. JP2006145857 (2006).
25. Frederickson CJ, Suh SW, Silva D, Frederickson CJ, Thompson RB. Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr 2000; 130: 1471S-83S.
26. Frederickson CJ. Neurobiology of zinc and zinc-containig neurons. Intern Review Neurobiol 1989; 31: 145-238.
27. Frederickson CJ, Klitenick MA, Manton WI, Kirkpatrick JB. Cytoarchitectonic distribution of zinc in the hippocampus of man and the rat. Brain Res 1983; 273: 335-39.
28. 2+ spillover modulates heterosynaptic N-methyl-D-aspartate receptor activity in hippocampal CA3 circuits. J Cell Biol 2002; 158:215-20.
29. Takoda A. Movement of zinc and its functional significance in the brain. Brain Res Brain Res Rev 2000; 34:137-48.
30. Hambidge M. Human zinc deficiency. J Nutr 2000; 130: 1344S-9S.
31. Weiss JH, Sensi SL, Koh JY. Zn(2+): a novel ionic mediator of neural injury in brain disease. Trends Pharmacol Sci 2000; 21: 395-401.
32. Koh JY and Choi DW. Zinc toxicity of cultured cortical neurons: involvement of N-methyl-D-asparatate receptors. Neuroscience 1994; 4: 1049-1057.
33. Koh JY, Suh SW, Gwag BJ, et al. The role of zinc in selective neuronal death after transient global cerebral ischemia. Science 1996; 272: 1013-16.
34. + and inhibition of glycolysis. J Neurosci 2000; 20:3139-3146.
35. Lee JM, Zipfel GJ, Park KH, et al. Zinc translocation accelerates infarction after mild transient focal ischemia. Neuroscience 2002; 115: 871-78.
36. Calderone A, Jover T, Mashiko T, et al. Late calcium EDTA rescues hippocampal CA1 neurons from global ischemia-induced death. J Neurosci 2004; 24: 9903-13.
37. 2+-permeable AMPA receptor channels primes cell death in transient forebrain ischemia. Neuron 2004; 43:43-55.
38. Noh KM, Yokota H, Mashiko T, et al. Blockade of calcium-permeable AMPA receptors protects hippocampal neurons against global ischemia-induced death. Proc Natl Acad Sci U S A. 2005; 102:12230-35.
39. Kwak S, Weiss JH. Calcium-permeable AMPA channels in neurodegenerative disease and ischemia. Curr Opin Neurobiol. 2006; 16:281-87.
40. Choi DW, Koh JY. Zinc and brain injury. Annu Rev Neurosci. 1998; 21:347-75.
41. Cai AL, Zipfel GJ, Sheline CT. Zinc neurotoxicity is dependent on intracellular NAD levels and the sirtuin pathway. Eur J Neurosci 2006; 24:2169-2176.
42. Lee JY, Kim YH, Koh JY. Protection by Pyruvate against Transient Forebrain Ischemia in Rats. J Neurosci 2001; 21: RC171.
43. Chen CJ, Liao SL. Zinc toxicity on neonatal cortical neurons: involvement of glutathione chelation. J Neurochem 2003; 85:443-53.
44. 2+ toxicity and modulation by ZnT-1 in PC12 Cells. Brain Res 2000; 886: 99-107.
45. Priel T, Aricha-Tamir B, Sekler I. Clioquinol attenuates zinc-dependent beta-cell death and the onset of insulitis and hyperglycemia associated with experimental type I diabetes in mice. Eur J Pharmacol 2007.
46. Nolte C, Gore A, Sekler I, et al. ZnT-1 expression in astroglial cells protects against zinc toxicity and slows the accumulation of intracellular zinc. Glia 2004; 48:145-55.
47. Mellon PL, Windle JJ, Goldsmith PC, et al. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 1990; 5: 1-10.
48. Mahesh VB, Zamorano P, De Sevilla L, Lewis D, Brann DW. Characterization of ionotropic glutamate receptors in rat hypothalamus, pituitary and immortalized gonadotropin-releasing hormone (GnRH) neurons (GT1-7 cells). Neuroendocrinology 1999; 69: 397-407.
49. Boldyrev AA. Problems and perspectives in studying the biological role of carnosine. Biochemistry (Mosc) 2000; 65:751-56.
50. Sewell DA, Harris RC, Marlin DJ, Dunnett M. Estimation of the carnosine content of different fibre types in the middle gluteal muscle of the thoroughbred horse. J Physiol 1992; 455: 447-53.
51. Abe H. Role of histidine-related compounds as intracellular proton buffering constituents in vertebrate muscle. Biochemistry (Mosc) 2000; 65: 757-65.
52. Urashima, K., Shiot, N., Ichihisa, K.: JP00201649 (2000).
53. Morimatsu, F., Taguchi, Y., Oomori K.: JP0251730 (2002).
54. Suzuki Y, Nakao T, Maemura H, et al. Carnosine and anserine ingestion enhances contribution of nonbicarbonate buffering. Med Sci Sports Exerc 2006; 38: 334-38.
55. Harris, R., Dunnett, M.: US5965596 (1999).
56. Matahira, Y., Kikuchi, K.: US20056855727 (2005).
57. Bonfanti L, Peretto P, De Marchis S, Fasolo A. Carnosine-related dipeptides in the mammalian brain. Prog Neurobiol 1999; 59:333-53.
58. Boldyrev AA. Does carnosine possess direct antioxidant activity? Int J Biochem 1993; 25:1101-7.
59. Naito Y, Yoshikawa T, Tanigawa T, et al. Zinc-carnosine chelate compound (Z-103) attenuates acute gastric mucosal injury induced by ischemia-reperfusion in rats. Adv Exp Med Biol 1990; 264: 411-14.
60. Hobart LJ. Seibel I, Yeargans GS, Seidler NW. Anti-crosslinking properties of carnosine: significance of histidine. Life Sci 2004; 75: 1379-89.
61. Hipkiss AR, Brownson C. Carnosine reacts with protein carbonyl groups: another possible role for the anti-ageing peptide? Biogerontology 2000; 1: 217-23.
62. Chen Y, Ho CT. Effects of carnosine on volatile generation from Maillard reaction of ribose and cysteine. J Agric Food Chem 2002; 50: 2372-76.
63. Takeuchi M, Kikuchi S, Sasaki N, et al. Involvement of advanced glycation end-products (AGEs) in Alzheimer's disease. Curr Alzheimer Res 2004, 1: 39-46.
64. Wang AM, Ma C, Xie ZH, Shen F. Use of carnosine as a natural anti-senescence drug for human beings. Biochemistry (Mosc) 2000; 65: 869-71.
65. Fujii T, Takaoka M, Tsuruoka N, et al. Dietary supplementation of L-carnosine prevents ischemia/reperfusion-induced renal injury in rats. Biol Pharm Bull 2005; 28: 361-63.
66. Cuzzocrea S, Genovese T, Failla M, et al. Protective effect of orally administered, carnosine on bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1095-104.
67. Dobrota D, Fedorova T, Stvolinsky S, et al. Camosine protects the brain of rats and Mongolian gerbils against ischemic injury: after-stroke-effect. Neurochem Res 2005; 30: 1283-88.
68. Wu XH, Ding MP, Zhu-Ge ZB, et al. Camosine, a precursor of histidine, ameliorates pentylenetetrazole-induced kindled seizures in rat. Neurosci Lett 2006; 400: 146-69.
69. Chez MG, Buchanan CP, Aimonovitch MC, et al. Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders. J Child Neurol 2002; 17: 833-37.
70. Bergstrom, J.: US5968966 (1999).
71. Zaloga, G. P. Roberts, P.: US5585396 (1996).
72. Yoshikawa, R., Kakutani, M, Ikushima, T.: JP0370452 (2003).
73. Tsuruoka, N., Kiso, Y., Nagai, K.: WO02076455 (2002).
74. Harada, M., Nagai, O.: JPH0920661 (1997).
75. Harada, M., Nakao, M., Hirai, K., Umeyama, T.: JPH0797323 (1995).
76. Williams DL, Munday P. The effect of a topical antioxidant formulation including N-acetyl camosine on canine cataract: a preliminary, study. Vet Ophthalmol 2006; 9: 311-16.
77. Aldini, G., Canevotti, R., Negrisolo, G.: EP1761272A1 (2007).
78. Matsukura, T., Tanaka H. Applicability of zinc complex of L-carnosine for medical use. Biochemistry (Mosc) 2000; 65: 817-23.
79. Matsukura, T., Takahashi, T., Nishimura, Y., Takaya, M., Fujimura, H.: US4981846 (1991).
80. Nishimura, Y., Matsukura, T.: WO0001091762 (2001).
81. Hirano, M. Katayama, S.: US20016169083 (2001).
82. Inagaki, T. Tagashira, E. Takaya, M. Nishimura, Y.: US4927817 (1990).
83. Yamagusch, M.: US5294634 (1994).
84. Hipkiss AR. Is carnosine a naturally occurring suppressor of oxidative damage in olfactory neurones? Rejuvenation Res 2004; 7:253-55.
85. Marchis SD, Modena C, Peretto P, et al. Carnosine-related dipeptides in neurons and glia. Biochemistry (Mosc) 2000; 65: 824-33.
86. Fonteh AN, Harrington RJ, Tsai A. Liao P, Harrington MG. Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids 2007; 32:213-24.
87. Preston JE, Hipkiss AR, Himsworth DT, Romero IA, Abbott JN. Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine. Neurosci Lett 1998; 242: 105-108.
88. Stuerenburg HJ, Kunze K. Concentrations of free carnosine (a putative membrane-protective antioxidant) in humnan muscle biopsies and rat muscles. Arch Gerontol Geriatr 1999; 29: 107-13.